Brinker Capital Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Buy |
12,474
+2,341
| +23% | +$39.2K | ﹤0.01% | 1870 |
|
|
2025
Q1 | $156K | Sell |
10,133
-2,169
| -18% | -$33.3K | ﹤0.01% | 1830 |
|
|
2024
Q4 | $271K | Buy |
12,302
+1,310
| +12% | +$28.9K | ﹤0.01% | 1603 |
|
|
2024
Q3 | $198K | Buy |
+10,992
| New | +$198K | ﹤0.01% | 1718 |
|
|
2016
Q4 | – | Sell |
-80
| Closed | -$4K | – | 638 |
|
|
2016
Q3 | $4K | Buy |
+80
| New | +$4K | ﹤0.01% | 427 |
|
|
2015
Q1 | – | Sell |
-200
| Closed | -$12K | – | 469 |
|
|
2014
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 356 |
|
|
2014
Q3 | $11K | Hold |
200
| – | – | ﹤0.01% | 327 |
|
|
2014
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 331 |
|
|
2014
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 348 |
|
|
2013
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 334 |
|
|
2013
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 335 |
|
|
2013
Q2 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 322 |
|